Probing the Time Dependency of Cyclooxygenase-1 Inhibitors by Computer Simulations

Yasmin Shamsudin1, Hugo Gutiérrez-de-Terán1, Johan Åqvist1

  • 1Department of Cell and Molecular Biology, Uppsala University , BMC, Box 596, SE-751 24 Uppsala, Sweden.

Biochemistry
|March 18, 2017
PubMed

Insights

Time-dependent inhibition of cyclooxygenase-1 (COX-1) involves a slow enzyme-inhibitor transition. This study reveals that specific inhibitors stabilize a conformational change in COX-1, crucial for tight-binding interactions.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Structural Biology

Background:

  • Time-dependent inhibition of cyclooxygenases (COX) by nonsteroidal anti-inflammatory drugs is a known phenomenon.
  • Slow tight-binding inhibitors of COX-1 exhibit a two-step binding mechanism (EI → EI*), with a slow and practically irreversible transition.

Purpose of the Study:

  • To investigate the structural basis of time-dependent inhibition of COX-1 by various inhibitors.
  • To identify specific enzyme features responsible for the time-dependent and tight-binding inhibition mechanisms.

Main Methods:

  • Molecular dynamics simulations
  • Binding free energy calculations
  • Potential of mean force calculations

Main Results:

  • Time-dependent inhibitors stabilize a specific conformational change in COX-1.
  • This conformational change is characterized by the rotation of a leucine side chain near the binding pocket.
  • The identified conformational change is essential for high binding affinities of tight-binding inhibitors.

Conclusions:

  • The structural features responsible for time-dependent and tight-binding inhibition in COX-1 are identical.
  • A specific structural mechanism driving the transition between enzyme-inhibitor complexes in slow tight-binding COX-1 inhibition has been identified.

Related Concept Videos

Stability of Substituted Cyclohexanes02:30

Stability of Substituted Cyclohexanes

This lesson discusses the stability of substituted cyclohexanes with a focus on energies of various conformers and the effect of 1,3-diaxial interactions.
The two chair conformations of cyclohexanes undergo rapid interconversion at room temperature. Both forms have identical energies and stabilities, each comprising equal amounts of the equilibrium mixture. Replacing a hydrogen atom with a functional group makes the two conformations energetically non-equivalent.
For example, in...
16.5K
Reaction Mechanisms: Rate-limiting Step Approximation01:29

Reaction Mechanisms: Rate-limiting Step Approximation

The rate-determining step, or RDS, in a chemical reaction is the slowest step that determines the overall reaction rate. It is identified by using the observed rate law and typically involves approximation methods like the RDS approximation or the steady-state approximation.In the RDS approximation, also known as the rate-limiting-step or equilibrium approximation, the reaction mechanism consists of one or more reversible reactions near equilibrium, followed by a slower RDS, and then one or...
20
Time Course of Drug Effect01:14

Time Course of Drug Effect

The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.8K
Chronopharmacokinetics: Time-Dependent Pharmacokinetics01:20

Chronopharmacokinetics: Time-Dependent Pharmacokinetics

Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
472
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
2.0K
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
65